Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 6, 2015, Pages 2245-2250

  Han, Li Hui ^a   Jia, Yi Bin ^a   Song, Qing Xu ^a   Wang, Jian Bo ^a   Wang, Na Na ^a   Cheng, Yu Feng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Clinical outcome; Esophageal squamous cell carcinoma; Lymphocyte monocyte ratio

Indexed keywords

ADULT; AGED; CANCER GRADING; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTE; MALE; MIDDLE AGED; MONOCYTE; MORTALITY; PATHOLOGY; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84929175044     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.6.2245     Document Type: Article

References (30)

1. Cihan YB, Arslan A, Cetindag MF, et al (2014). Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer. Asian Pac J Cancer Prev, 15, 4225-31.
2. Colotta F, Allavena P, Sica A, et al (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 30, 1073-81.
3. Dutta S, Crumley AB, Fullarton GM, et al (2011). Comparison of the prognostic value of tumour-and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg, 35, 1861-6.
4. Feng JF, Huang Y, Chen QX (2014). Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol, 12, 58.
5. Fujiwara Y, Misawa T, Shiba H, et al (2014). Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma. Anticancer Res, 34, 5163-8.
6. Li YL, Gu KS, Pan YY, et al (2014). Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. BMC Cancer, 14, 341.
7. Lin GN, Peng JW, Xiao JJ, et al (2014). Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet. Med Oncol, 31, 70.
8. Liu J, Xie X, Zhou C, et al (2012). Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg, 41, 7-11.
9. Mantovani A, Allavena P, Sica A, et al (2008). Cancer-related inflammation. Nature, 454, 436-44.
10. Mantovani A, Schioppa T, Porta C, et al (2006). Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev, 25, 315-22.
11. Mlecnik B, Tosolini M, Kirilovsky A, et al (2011). Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol, 29, 610-8.
12. Ownby HE, Roi LD, Isenberg RR, et al (1983). Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer, 52, 126-30.
13. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013). Oesophageal carcinoma. Lancet, 381, 400-12.
14. Porrata LF, Ristow K, Colgan JP, et al (2012). Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica, 97, 262-9.
15. Porrata LF, Ristow KM, Habermann TM, et al (2013). Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma. Blood Cancer J, 3, 110.
16. Rashid F, Waraich N, Bhatti I, et al (2010). A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol, 8, 1.
17. Rosenberg SA (1996). The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens. Annu Rev Med, 47, 481-91.
18. Sharaiha RZ, Halazun KJ, Mirza F, et al (2011). Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol, 18, 3362-9.
19. Shen SL, Fu SJ, Huang XQ, et al (2014). Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection. BMC Cancer, 14, 744.
20. Shigeoka M, Urakawa N, Nakamura T, et al (2013). Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci, 104, 1112-9.
21. Stotz M, Pichler M, Absenger G, et al (2014). The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer, 110, 435-40.
22. Subimerb C, Pinlaor S, Lulitanond V, et al (2010). Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol, 161, 471-9.
23. Szkandera J, Gerger A, Liegl-Atzwanger B, et al (2014). The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer, 135, 362-70.
24. Tang X (2013). Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Letters, 332, 3-10.
25. Templeton AJ, Ace O, McNamara MG, et al (2014a). Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev, 23, 1204-12.
26. Templeton AJ, McNamara MG, Seruga B, et al (2014b). Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst, 106, 124.
27. Tsai YD, Wang CP, Chen CY, et al (2014). Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck, 36, 947-53.
28. Ubukata H, Motohashi G, Tabuchi T, et al (2010). Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol, 102, 742-7.
29. Yoo EJ, Park JC, Kim EH, et al (2014). Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer. Dig Liver Dis, 46, 846-53.
30. Zhou X, Du Y, Xu J, et al (2014). The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol, 35, 11659-66.